XML 105 R63.htm IDEA: XBRL DOCUMENT v3.25.1
Share-based compensation - Plans (Details) - $ / shares
1 Months Ended 12 Months Ended
Jan. 01, 2025
Oct. 02, 2023
Jun. 28, 2023
Sep. 30, 2020
Aug. 31, 2020
Dec. 31, 2024
Oct. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Shares available for future issuance           15,528,401   13,202,327
Options, Granted           6,616,169    
Granted           $ 14.66    
Dr. Clay Siegall | Morphimmune Inc                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Options, Granted     2,137,080          
Granted     $ 5.91          
Dr. Clay Siegall | Morphimmune Inc | One-year anniversary                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of vesting   25.00%            
Dr. Clay Siegall | Morphimmune Inc | Over next 36 months                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of vesting   75.00%            
Vesting period   36 months            
2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Threshold Percentage Of Total Number Of Common Stock Outstanding         4.00%      
Shares available for future issuance           1,698,331    
Expiration period           10 years    
2020 Plan | Subsequent events                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Increase in shares available for future issuance 2,578,433              
2020 Plan | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period           4 years    
2020 Plan | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period           1 year    
2024 Inducement Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Shares available for future issuance             2,000,000  
Shares available for grant           559,300    
MorphImmune Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Shares available for future issuance   373,738            
Employee Stock Purchase Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Authorized stock options           125,000    
Employee Stock Purchase Plan, Threshold Period For Which Common Stock Is Automatically Added To Arrive At Authorized Shares           10 years    
Percentage of outstanding capital stock           1.00%    
Purchase price percentage       85.00%        
Maximum number of shares that can be purchased       15.00%        
Number of common shares added in authorized           1,000,000    
Shares available for grant           906,251   473,733
Awards granted           0    
Employee Stock Purchase Plan | Subsequent events                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Increase in shares available for future issuance 644,608